Editorial Type: Case Reports
 | 
Online Publication Date: 01 Aug 2014

A Case of Cutaneous Sterile Pyogranuloma/Granuloma Syndrome in a Maltese

PhD, DVM,
PhD, DVM,
PhD,
PhD, DVM,
PhD, DVM, DAiCVO,
PhD, DVM, DJCVP, and
PhD, DVM, DJCVP
Article Category: Case Report
Page Range: 278 – 283
DOI: 10.5326/JAAHA-MS-6009
Save
Download PDF

Cutaneous sterile pyogranuloma/granuloma syndrome (SPGS) is a locally restricted multinodular dermatitis. Affected dogs are typically healthy, but a few show systemic signs. Herein, a case of a dog presenting with generalized ulcerative dermatitis with systemic signs of mild anemia and an increased C-reactive protein level is described. Cutaneous SPGS was diagnosed by histopathology, negative staining causative organisms, and polymerase chain reaction for Mycobacterium spp. Successful treatment was achieved by immunosuppressive drugs, including prednisolone and azathioprine, administered for at least 20 mo. Recurrences of skin lesions were observed when prednisolone and/or azathioprine were discontinued. Long-term management with immunosuppressive agents may be required if the affected dog exhibits severe symptoms of cutaneous SPGS.

Introduction

Cutaneous sterile pyogranuloma/granuloma syndrome (SPGS) is a skin disease that is uncommon in dogs and extremely rare in cats.14 In the literature, SPGS is also termed idiopathic periadnexal multinodular granulomatous dermatitis.2 No age or gender predisposition is reported; however, boxers, golden retrievers, collies, Great Danes, and Weimaraners may be predisposed, and male dogs seem to be affected at a higher frequency.15 Characteristic skin lesions are usually observed on the bridge of the nose, muzzle, periocular region, pinnae, and paws.15 These lesions comprise dermal papules and nodules, which are multiple, well demarcated, firm, painless, and nonpruritic.15 They may become alopecic and ulcerated and may get secondarily infected, particularly on the paws.15 Although systemic signs such as lymphadenopathy and hypercalcemia have been reported in dogs and cats, the affected animals are typically healthy.17

The diagnosis of cutaneous SPGS is challenging and can be made only after ruling out other granulomatous and pyogranulomatous skin diseases.14 According to Santoro et al. (2008), the etiology of granulomatous and pyogranulomatous skin diseases can be divided into two major groups. The first group is infectious diseases caused by protozoans, mycobacteria, pathologic dimorphic fungi, etc. and noninfectious diseases with a known etiology such as a foreign body, hair, sebum, etc. The second group includes unknown etiologies, such as idiopathic “sterile” dermatitis.4 Histopathologically, those criteria were also based on visible infectious and known etiological agents and etiologic agents not detectable by analytical methods and possible immune-mediated (idiopathic) mechanisms. Some organisms such as Mycobacterium spp. and Leishmania spp. are not easily detected by histopathology; therefore, polymerase chain reaction (PCR) analysis is required.4,7,8 A diagnosis of cutaneous SPGS can be made after ruling out noninfectious granulomas of unknown etiologies, such as reactive histiocytosis, juvenile sterile granulomatous dermatitis and lymphadenitis, cutaneous xanthoma, and canine sarcoidosis.14

Herein, the successful long-term treatment of a dog presenting with cutaneous SPGS characterized by generalized ulcerative dermatitis, systemic signs of mild anemia, and an increased C-reactive protein (CRP) level is described. Cutaneous SPGS was diagnosed by histopathology, negative staining, and PCR for Mycobacterium spp.

Case Report

An indoor 3 yr old castrated male Maltese weighing 4.2 kg was referred to the Veterinary Teaching Hospital, Azabu University, with generalized ulcerative dermatitis. Initially, the skin lesions occurred on the dog’s head, identified by mild scales. The lesions progressed to crusting and multifocal ulcers, which spread to the head, dorsal and ventral trunk, and limbs over a period of 8 mo. Prior to being referred, the dog was administered systemic antibacterial and antifungal drugs [30 mg/kg cephalexin per os (PO) q 12 hr and 6 mg/kg ketoconazole PO q 12 hr, respectively] for 4 wk; however, the dog was unresponsive. Physical and dermatological examinations, bacterial culture with antimicrobial susceptibility testing, fungal culture, blood tests, diagnostic imaging, urinalysis, arthrocentesis, skin biopsy, and histopathological examinations were subsequently performed at the time of referral.

On physical examination, the dog presented with severe pain, mild pruritus of the skin, and a body temperature of 39°C. Bilateral lymphadenopathy of the superficial cervical and popliteal lymph nodes was observed. Skin lesions comprised alopecia and erythema with epidermal detachment and multifocal ulcers with crusting. Although haired skin on the top of the muzzle remained, demarcated alopecic skin lesions were observed on the dog’s face, including the periocular, periauricular regions, and the planum nasale from the top of the muzzle to the head. Other affected areas were the dorsal trunk, extending from the neck to the front of the tail; the ventral trunk extending from the anterior chest; and the axilla to the inguinal region, limbs, paws, and perianal region (Figure 1). Impression smears were obtained from the ulcerative skin lesions of the dorsal and ventral regions and stained by the Wright’s-Giemsa method. Cytology revealed a pyogranulomatous inflammation comprising macrophages and nondegenerate neutrophils; however, acantholytic keratinocytes, bacteria such as cocci and bacilli, and Malassezia spp. were not apparent. Infection with Demodex canis was ruled out by skin scraping and hair plucking, and sarcoptic mange was ruled out by only mild pruritus of the skin.

FIGURE 1. Photographs of the dog’s head (A), right paw (B), dorsal region (C), and ventral region (D) on day 1 showing alopecia and erythematous dermatitis with ulcerative plaques.FIGURE 1. Photographs of the dog’s head (A), right paw (B), dorsal region (C), and ventral region (D) on day 1 showing alopecia and erythematous dermatitis with ulcerative plaques.FIGURE 1. Photographs of the dog’s head (A), right paw (B), dorsal region (C), and ventral region (D) on day 1 showing alopecia and erythematous dermatitis with ulcerative plaques.
FIGURE 1 Photographs of the dog’s head (A), right paw (B), dorsal region (C), and ventral region (D) on day 1 showing alopecia and erythematous dermatitis with ulcerative plaques.

Citation: Journal of the American Animal Hospital Association 50, 4; 10.5326/JAAHA-MS-6009

Hematologic analysis revealed results within reference ranges, except for a slight decrease in the red blood cell count (3.92 × 1012/L; reference range, 5.5–8.5 × 1012/L) and packed cell volume (0.31%; reference range,) and a remarkable increase in CRP level (142.86 nmol/L; reference range 0.37–0.55, < 9.52 nmol/L) as described in Table 1. After severe inflammation was suspected in the dog, CRP level was monitored using a laser nephelometric immunoassay systema for dogs.9 Serum protein electrophoresis revealed an increased α2-globulin fraction level, but did not indicate gammopathy.

TABLE 1 Complete Blood Cell Count, Serum Biochemical Profile, and Urinalysis Results on the Day of Referral
TABLE 1

Differential diagnoses from the findings at the first visit were both aerobic and anaerobic bacteria, including Nocardia and Actinomyces spp.; deep and intermediate fungi; dermatophytosis; pemphigus foliaceus; pemphigus vulgaris; erythematosus paraneoplastic pemphigus; discoid lupus erythematosus; systemic lupus erythematosus; cutaneous lymphoma; erythema multiforme; cutaneous vasculitis; toxic epidermal necrolysis; hepatocutaneous syndrome; and idiopathic ulcerative dermatosis.

Antimicrobial susceptibility testing was conducted at Hoken Kagaku Laboratory (Kanagawa, Japan) using the Clinical Laboratory Standards Institute method. Aerobic bacterial culture from a swab of a dorsal ulcerative skin lesion using sheep blood agar was negative. Although the association of anaerobic bacteria could not be ruled out, anaerobic culture was not performed because the ulcerative lesion was aerobically exposed on the superficial epidermis. Fungal culture performed and analyzed at Hoken Kagaku Laboratory from the same skin lesion was negative. Sabouraud agar, which is used for detection of dermatophytes, yeast-like organisms, and Cryptococcus spp., was used for the culture. Because specific bacterial and fungal features were not identified by the impression smears, macerated tissue culture and specialized culture were not performed.

Thoracic and abdominal radiographs and ultrasonography did not reveal any apparent abnormalities. Dermatoses associated with systemic diseases such as paraneoplastic pemphigus and hepatocutaneous syndrome was ruled out because none of findings indicated either a tumor mass or a remarkable abnormality of the liver parenchyma. To examine the possibility of systemic lupus erythematosus, urinalysis (Table 1), and arthrocentesis of synovial fluid from the left knee joint were performed. Urine test strips were positive for protein (2+) and negative to occasionally positive leukocytes, nitrate, urobilinogen, blood, ketones, bilirubin, and glucose. Zero to occasional red blood cells, white blood cells, and transitional cells were seen, but no crystals or casts were detected by urinary sediment examination. The synovial fluid was clear, colorless, and extremely viscous. Cytology revealed a few large and small mononuclear inflammatory cells, which was not suggestive of arthropathy.

Specimens were collected using a 4 mm punch biopsy from skin lesions on the dog’s head and dorsal trunk. Histopathology revealed a nodular to diffuse dermatitis characterized by intense lymphohistiocytic infiltration and fibrosis involving the superficial dermis and subcutis (Figure 2). The adnexa, such as the hair follicles and sebaceous glands, were obscured by fibrosis. Deposition of autoantibodies in the tissue was not detected by immunofluorescence using fluorescein isothiocyanate-labeled anti-dog immunoglobulin (Ig) G antibodiesb (diluted 1:800). Based on the histopathological evaluation, pemphigus foliaceus, pemphigus vulgaris, and systemic and discoid lupus erythematosus, cutaneous lymphoma, erythema multiforme, cutaneous vasculitis, toxic epidermal necrolysis, and idiopathic ulcerative dermatosis were ruled out. Histopathological analysis revealed the presence of nodular granuloma, which suggested a deep pyoderma and fungal infection by an antibiotic-resistant microorganism, atypical mycobacteriosis (canine leproid granuloma syndrome), and cutaneous SPGS. Cutaneous leishmaniasis was ruled out because it is not endogenous to Japan and the dog has never been outside Japan. Periodic acid-Schiff, Ziehl-Neelsen, Grocott’s methenamine silver, and gram staining were used, but failed to detect any etiologic agent in the tissue specimens.

FIGURE 2. A: Nodular to diffuse dermatitis characterized by intense lymphohistiocytic infiltration and fibrosis throughout the superficial dermis and subcutis. B: A nodular lesion mainly comprised of macrophages and neutrophils in the subcutis. Hematoxylin and eosin stain, bar represents 500 μm (A) and 100 μm (B).FIGURE 2. A: Nodular to diffuse dermatitis characterized by intense lymphohistiocytic infiltration and fibrosis throughout the superficial dermis and subcutis. B: A nodular lesion mainly comprised of macrophages and neutrophils in the subcutis. Hematoxylin and eosin stain, bar represents 500 μm (A) and 100 μm (B).FIGURE 2. A: Nodular to diffuse dermatitis characterized by intense lymphohistiocytic infiltration and fibrosis throughout the superficial dermis and subcutis. B: A nodular lesion mainly comprised of macrophages and neutrophils in the subcutis. Hematoxylin and eosin stain, bar represents 500 μm (A) and 100 μm (B).
FIGURE 2 A: Nodular to diffuse dermatitis characterized by intense lymphohistiocytic infiltration and fibrosis throughout the superficial dermis and subcutis. B: A nodular lesion mainly comprised of macrophages and neutrophils in the subcutis. Hematoxylin and eosin stain, bar represents 500 μm (A) and 100 μm (B).

Citation: Journal of the American Animal Hospital Association 50, 4; 10.5326/JAAHA-MS-6009

Using the primers described by Cornegliani et al. (2005), PCR was performed to detect Mycobacterium spp.8 DNA extraction from paraffin-embedded tissues was conducted using a commercial kitc. Five microliters of the extracted DNA solution were used for the nested PCR amplification of a 16S rRNA fragment with a DNA polymerased using a gradient thermal cyclere. The external primers (FO16S, 5′-GATAAGCCTGGGAAACTGGGTC-3′; RO16S, 5′-TTCTCCACCTACCGTCAATCCG-3′) were used to amplify a 344-base pair fragment and the internal primers (F116S, 5′-CATGTCTTGTGGTGGAAAGCG-3′; RI16S, 5′-TACCGTCAATCCGAGAGAACCC-3′) were used to amplify a 288-base pair fragment. The first and second PCR amplification consisted of one cycle at 98°C for 3 min, followed by 35 cycles of denaturation (98°C for 30 sec), annealing (65.7°C for 30 sec), and extension (72°C for 30 sec). The PCR products were separated by 2% agarose gel electrophoresis, stained with ethidium bromide, and visualized using an UV transilluminatorf. DNA was extracted from a BCG vaccine straing and used as a positive control. The PCR results were negative, and mycobacteriosis was ruled out in the present case.

Clinical findings (age of onset and breed), histopathological findings, and diagnostic imaging results ruled out the other noninfectious granulomas of unknown etiologies; therefore, a diagnosis of cutaneous SPGS was considered most suitable for the present case. Consequently, prednisoloneh (1 mg/kg PO q 12 hr) and fosfomycin Ca hydratei (25 mg/kg PO q 12 hr) therapy was initiated. In addition, as a supportive therapy, famotidinej (1 mg/kg PO q 12 hr) and ursodeoxycholic acidk (10 mg/kg PO q 12 hr) was administered for protection against the adverse effects of prednisolone. The treatment of skin barrier restoration included 0.5% vitamin A oill and a topical corticosteroid preparation comprising 0.12% betamethasone valeratem and 0.3% heparinoidn. One wk after the initiation of therapy (day 7), the ulcerative dermatitis improved and CRP level decreased (4.76 nmol/L). After 1 mo (28 days), the dog was free of grossly visible ulcerative skin lesions (Figures 3A–C) and the packed cell volume increased to 43%. Subsequently, the dose of prednisolone was tapered by 0.5 mg/kg BW at 2 wk intervals and administration of azathioprineo (1 mg/kg PO q 24 hr) was initiated. After decreasing the dose of prednisolone to 0.5 mg/kg q 48 hr (day 82), it was further decreased to q 72 hr for 2 mo (day 110). Following the cessation of prednisolone on day 138, mild skin lesions with crusting and erosion were observed on the dorsum of the neck on day 166 (Figures 3D, E). Those relapses were treated with prednisolone, and the dosage of azathioprine was decreased to 1 mg/kg q 48 hr. Maintenance doses of prednisolone (0.5 mg/kg q 48 hr) and azathioprine (1 mg/kg q 48 hr) were selected on day 197; however, the owner had administered a single dose of prednisolone (0.5 mg/kg) 1–2 times/wk according to the owner’s judgment, although the dog received azathioprine as scheduled. At a 3 mo routine follow-up examination (day 278), the dog exhibited mild skin lesions of erythema and crusting on the limbs and dorsal and ventral trunk. A fungal culture using a dermatophyte test agar medium was negative. The owner was reminded to continue prednisolone. The skin symptoms did not become aggravated and remained unchanged for at least 9 mo. However, on day 537 during a routine follow-up examination, the owner reported an apparent recurrence of pruritus and crusting on the dog’s face and back within 2 wk after discontinuing prednisolone and azathioprine. The recurrent lesions were treated with prednisolone and azathioprine that were prescribed by the referring veterinarian. No hair regrowth was observed during the course of the treatment (day 624).

FIGURE 3. Photographs of the head (A), right paw (B), dorsal region (C), ventral neck (D), and ventral abdomen (E) indicating that the erythematous dermatitis and ulcerative plaques improved by day 28; however, no hair regrowth was observed (A, B, and C). A recurrence of skin lesions was observed on day 166 after discontinuation of prednisolone (D, E).FIGURE 3. Photographs of the head (A), right paw (B), dorsal region (C), ventral neck (D), and ventral abdomen (E) indicating that the erythematous dermatitis and ulcerative plaques improved by day 28; however, no hair regrowth was observed (A, B, and C). A recurrence of skin lesions was observed on day 166 after discontinuation of prednisolone (D, E).FIGURE 3. Photographs of the head (A), right paw (B), dorsal region (C), ventral neck (D), and ventral abdomen (E) indicating that the erythematous dermatitis and ulcerative plaques improved by day 28; however, no hair regrowth was observed (A, B, and C). A recurrence of skin lesions was observed on day 166 after discontinuation of prednisolone (D, E).
FIGURE 3 Photographs of the head (A), right paw (B), dorsal region (C), ventral neck (D), and ventral abdomen (E) indicating that the erythematous dermatitis and ulcerative plaques improved by day 28; however, no hair regrowth was observed (A, B, and C). A recurrence of skin lesions was observed on day 166 after discontinuation of prednisolone (D, E).

Citation: Journal of the American Animal Hospital Association 50, 4; 10.5326/JAAHA-MS-6009

Discussion

At the time of referral, the study authors considered a diagnosis of pustular skin disease; however, based on the histopathological findings of granulomatous dermatitis, that diagnosis was changed to granulomatous and pyogranulomatous skin disease. Based on the criteria described by Santoro et al. (2008), a diagnosis of cutaneous SPGS was made.4

The etiology and pathogenesis of cutaneous SPGS is unknown.18 The absence of infectious agents and foreign materials together with a good response to systemic glucocorticoids suggested the involvement of immune-mediated mechanisms.17 In the present case, neither causative organisms nor foreign bodies were detected by culture, impression smears, special histopathological staining, or PCR for Mycobacterium spp. Because Leishmania spp. is not endogenous to Japan, diagnoses were only made for Mycobacterium spp.4,8 Although potentially infectious bacteria, such as antimicrobial-resistant bacteria, anaerobic bacteria, and bacteria requiring special culture methods, were not ruled out, the authors attempted to limit the possibility of infection using fosfomycin. Fosfomycin is a broad-spectrum antibiotic for gram-positive and gram-negative bacteria and is well distributed in tissues with clinically relevant concentrations in the serum, kidneys, bladder wall, prostate, lungs, inflamed tissues, bone, cerebrospinal fluid, abscess fluid, and heart valves.10 The efficacy of fosfomycin against cephalexin-resistant Staphylococcus spp. isolated from a patient with pyoderma and otitis externa has been reported in Japan.11 In the present case, systemic inflammation was indicated by fever, an increased CRP level, and lymphadenopathy. The dog was also treated with immunosuppressive drugs, including prednisolone and azathioprine, although recurrences of skin lesions were observed when both drugs were discontinued. Those findings suggested that systemic inflammation, which was treated with prednisolone and azathioprine, was associated with the pathogenesis in the present case.

Hair regrowth was not observed even after successful treatment with prednisolone and azathioprine, possibly due to the presence of extensive fibrosis involving the superficial dermis and subcutis at the site of adnexa. The dermal papilla and the bulge region, where arrector pili muscles insert into hair follicles, are considered to contain stem cells capable of hair and skin regeneration.12,13 The presence of fibrosis suggested severe inflammation that possibly destroyed the hair follicles and sebaceous glands at the affected sites.

In the present case, lymphohistiocytic infiltrations were observed by histopathology; however, deposition of the IgG antibody was not detected using immunofluorescence. It has been proposed that cutaneous SPGS is associated with immune dysfunction in response to chronic antigenic stimulation.1 The absence of IgG autoantibodies suggested that the pathogenesis of the diseases was not associated with humoral-mediated immunity (as observed in pemphigus complex) but with cell-mediated immunity, in which effecter cells comprise macrophages and lymphocytes, as observed in the present case. The examination of surface cluster of differentiation antigens and major histocompatibility complex molecules on infiltrated cells could provide clues to elucidate the immune mechanisms involved in cutaneous SPGS.

Conclusion

Cutaneous SPGS is an uncommon skin disease in dogs.14 The affected animals are typically healthy, but a few exhibit systemic signs.17 This report documented a case of SPGS diagnosed by histopathological findings of a nodular to diffuse granulomatous dermatitis with intense lymphohistiocytic infiltration, negative staining for causative organisms, and PCR for Mycobacterium spp. The dog presented with generalized ulcerative dermatitis and systemic signs of mild anemia and an increased CRP level. Successful treatment was achieved by administration of immunosuppressive drugs (prednisolone and azathioprine) for at least 20 mo. Recurrence of skin lesions after cessation of prednisolone and/or azathioprine was observed, suggesting that long-term management using immunosuppressive drugs may be required if the dog exhibits severe systemic signs of cutaneous SPGS.

Acknowledgments

The authors would like to thank Tadayoshi Yamaguchi (Ann Animal Hospital) for providing the initial information, Yoko Kakinuma (Research Institute of Biosciences, Azabu University) for technical assistance with the histologic sections, Takahiro Hamada (Kurume University) for his advice regarding the present case, Dr. Ryoji Takahashi and Dr. Yusuke Matsuura (Veterinary Teaching Hospital, Azabu University) for supporting patient care, and Jonathan Bloch (Service Employees International Union Training and Education Funds, Renton, WA) for proofreading the manuscript. This report was partially supported by a project grant (Young Scientist Research Training Award, 2010 and 2011) funded by the Azabu University Research Service Division and Grant-in-Aid for Young Scientists (B) by the Japan Society for the Promotion of Science (23780330). The authors declare that there are no conflicts of interest associated with the present report.

REFERENCES

  • 1.
    Scott DW , MillerWH, GriffinCE, eds. Miscellaneous skin diseases. In: Muller and Kirk's Small Animal Dermatology.
    6th ed
    .
    Philadelphia (PA)
    :
    WB Saunders
    ; 2001:113640.
  • 2.
    Torres SMF . Sterile nodular dermatitis in dogs. Vet Clin North Am Small Anim Pract1999;29(
    6
    ):131123.
  • 3.
    Gross TL , IhrkePJ, WalderEJ, et al., eds. Noninfectious nodular and diffuse granulomatous and pyogranulomatous diseases of the dermis. In: Skin diseases of dog and cat: Clinical and histopathologic diagnosis.
    2nd ed
    .
    Oxford, UK
    :
    Blackwell Publishing
    ; 2005:3203.
  • 4.
    Santoro D , PriscoM, CiaramellaP. Cutaneous sterile granulomas/pyogranulomas, leishmaniasis and mycobacterial infections. J Small Anim Pract2008;49(
    11
    ):55261.
  • 5.
    Panich R , ScottDW, MillerWH. Canine cutaneous sterile granulomas/pyogranulomas syndrome: a retrospective analysis of 29 cases (1976 to 1988). J Am Anim Hosp Assoc1991;27:51928.
  • 6.
    Barrett SJ , SheaforSE, HillierA, et al. Challenging cases in internal medicine: what’s your diagnosis?Vet Med1998;93:3544.
  • 7.
    Santoro D , SpaternaA, MechelliL, et al. Cutaneous sterile pyogranuloma/granuloma syndrome in a dog. Can Vet J2008;49(
    12
    ):12047.
  • 8.
    Cornegliani L , FondevilaD, VercelliA, et al. PCR technique detection of Leishmania spp. but not Mycobacterium spp. in canine cutaneous ‘sterile’ pyogranuloma/granuloma syndrome. Vet Dermatol2005;16(
    4
    ):2338.
  • 9.
    Onishi T , InokumaH, OhnoK, et al. C reactive protein concentration in normal and diseased dogs measured by laser nephelometric immunoassay. J Jpn Vet Med Assoc2000;53:595601 [in Japanese with English summary].
  • 10.
    Michalopoulos AS , LivaditisIG, GougoutasV. The revival of fosfomycin. Int J Infect Dis2011;15(
    11
    ):e7329.
  • 11.
    Yakuyama T , NamikawaK, IchikawaY, et al. Antimicrobial drug susceptibility of Staphylococcus clinical isolate from canine pyoderma and external otitis. Jpn J Vet Dermatol2008;14(
    3
    ):1357.
  • 12.
    Mercati F , PascucciL, CeccarelliP, et al. Expression of mesenchymal stem cell marker CD90 on dermal sheath cells of the anagen hair follicle in canine species. Eur J Histochem2009;53(
    3
    ):15966.
  • 13.
    Mercati F , PascucciL, GargiuloAM, et al. Immunohistochemical evaluation of intermediate filament nestin in dog hair follicles. Histol Histopathol2008;23(
    9
    ):103541.

Footnotes

    CRP C-reactive protein Ig immunoglobulin PCR polymerase chain reaction PO per os SPGS sterile pyogranuloma/granuloma syndrome
  1. Canine CRP measurement system CRP-2; Arrows Co. Ltd., Osaka, Japan

  2. Fluorescein-conjugated goat affinity purified antibody to dog IgG (whole molecule); MP Bio Japan K.K., Tokyo, Japan

  3. DEXPAT; Takara Bio Inc., Siga, Japan

  4. MightyAmp DNA Polymerase Ver. 2; Takara Bio Inc., Siga, Japan

  5. MJ Mini; Bio-Rad Laboratories, Hercules, CA

  6. DigDoc-It Imaging System; UVP, CA

  7. BCG vaccine strain; Japan BCG Laboratory, Tokyo, Japan

  8. Prednisolone; Sanwa Kagaku Kenkyusho Co. Ltd., Aichi, Japan

  9. FOSMICIN; Meiji Seika Pharma Co. Ltd., Tokyo, Japan

  10. Gaster; Astellas, Tokyo, Japan

  11. URSO; Mitsubishi Tanabe Pharma Co., Osaka, Japan

  12. Sahne Oint; Eisai, Tokyo, Japan

  13. Rinderon-V Ointment; Shionogi Co. Ltd., Osaka, Japan

  14. Hirudoid Soft Ointment; Maruho, Osaka, Japan

  15. Imuran; Glaxo Smith Kline, Tokyo, Japan

Copyright: © 2014 by American Animal Hospital Association 2014
FIGURE 1
FIGURE 1

Photographs of the dog’s head (A), right paw (B), dorsal region (C), and ventral region (D) on day 1 showing alopecia and erythematous dermatitis with ulcerative plaques.


FIGURE 2
FIGURE 2

A: Nodular to diffuse dermatitis characterized by intense lymphohistiocytic infiltration and fibrosis throughout the superficial dermis and subcutis. B: A nodular lesion mainly comprised of macrophages and neutrophils in the subcutis. Hematoxylin and eosin stain, bar represents 500 μm (A) and 100 μm (B).


FIGURE 3
FIGURE 3

Photographs of the head (A), right paw (B), dorsal region (C), ventral neck (D), and ventral abdomen (E) indicating that the erythematous dermatitis and ulcerative plaques improved by day 28; however, no hair regrowth was observed (A, B, and C). A recurrence of skin lesions was observed on day 166 after discontinuation of prednisolone (D, E).


Contributor Notes

Correspondence: kawarai@azabu-u.ac.jp (S.K.)
  • Download PDF